Indication

post-acute COVID-19 syndrome

2 clinical trials

2 products

Clinical trial
Amantadine Therapy for Cognitive Impairment Related to Post-COVID Condition
Status: Recruiting, Estimated PCD: 2025-04-15
Product
Amantadine